A phase II study to evaluate the effect of dalteparin and radiation therapy (XRT) on survival compared to the RTOG RPA database and on thromboembolic events in patients with newly diagnosed glioblastoma multiforme (GBM): A trial of the Eastern Cooperative Oncoloby Group (ECOG) Conference

Robins, H Ian, O'Neill, Anne, Sapiente, Ronald et al. (2006). A phase II study to evaluate the effect of dalteparin and radiation therapy (XRT) on survival compared to the RTOG RPA database and on thromboembolic events in patients with newly diagnosed glioblastoma multiforme (GBM): A trial of the Eastern Cooperative Oncoloby Group (ECOG) . NEURO-ONCOLOGY, 8(4), 450-451.

cited authors

  • Robins, H Ian; O'Neill, Anne; Sapiente, Ronald; Olsen, Mark; Gilbert, Mark; Berkey, Brian; Mehta, Minesh

authors

date/time interval

  • September 14, 2006 -

publication date

  • October 1, 2006

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • Vienna, AUSTRIA

Conference

  • 7th Congress of the European-Association-for-Neuro-Oncology (EANO)

publisher

  • DUKE UNIV PRESS

start page

  • 450

end page

  • 451

volume

  • 8

issue

  • 4